Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Efficacy of Neoadjuvant Gemcitabine and Cisplatin Chemotherapy for cT3N0M0 Upper Tract Urothelial Carcinoma: The Impact of Tumor Location.
Kohada Y, Hayashi T, Takemoto K, Miyamoto S, Babasaki T, Kobatake K, Kitano H, Ikeda K, Goto K, Hieda K, Honda Y, Sentani K, Oue N, Awai K, Hinata N. Kohada Y, et al. Among authors: ikeda k. Urol J. 2023 Aug 27;21(02):98-106. doi: 10.22037/uj.v20i.7611. Online ahead of print. Urol J. 2023. PMID: 37634073 Free article.
Prostate cancer detection by prostate-specific antigen-based screening in the Japanese Hiroshima area shows early stage, low-grade, and low rate of cancer-specific death compared with clinical detection.
Teishima J, Maruyama S, Mochizuki H, Oka K, Ikeda K, Goto K, Nagamatsu H, Hieda K, Shoji K, Matsubara A. Teishima J, et al. Among authors: ikeda k. Can Urol Assoc J. 2014 May;8(5-6):E327-32. doi: 10.5489/cuaj.1715. Can Urol Assoc J. 2014. PMID: 24940459 Free PMC article.
Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy.
Teishima J, Kobatake K, Hayashi T, Seno Y, Ikeda K, Nagamatsu H, Hieda K, Shoji K, Miyamoto K, Inoue S, Kobayashi K, Ohara S, Kajiwara M, Matsubara A. Teishima J, et al. Among authors: ikeda k. Oncol Lett. 2014 Aug;8(2):881-885. doi: 10.3892/ol.2014.2207. Epub 2014 Jun 2. Oncol Lett. 2014. PMID: 25013512 Free PMC article.
Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction.
Kobatake K, Ikeda KI, Nakata Y, Yamasaki N, Ueda T, Kanai A, Sentani K, Sera Y, Hayashi T, Koizumi M, Miyakawa Y, Inaba T, Sotomaru Y, Kaminuma O, Ichinohe T, Honda ZI, Yasui W, Horie S, Black PC, Matsubara A, Honda H. Kobatake K, et al. Among authors: ikeda ki. Clin Cancer Res. 2020 Apr 15;26(8):2065-2079. doi: 10.1158/1078-0432.CCR-19-2230. Epub 2020 Feb 11. Clin Cancer Res. 2020. PMID: 32047002
Renal metastasis from primary hepatocellular carcinoma: a case report.
Yamanaka R, Sekino Y, Babasaki T, Kitano H, Ikeda K, Goto K, Hieda K, Inoue S, Hayashi T, Teishima J, Aikata H, Chayama K, Sentani K, Yasui W, Matsubara A. Yamanaka R, et al. Among authors: ikeda k. Int Cancer Conf J. 2020 Mar 25;9(3):141-145. doi: 10.1007/s13691-020-00409-3. eCollection 2020 Jul. Int Cancer Conf J. 2020. PMID: 32582519 Free PMC article.
7,195 results